Alimentary Pharmacology & Therapeutics

Articles Available on Medscape

• Real-World Effectiveness and Safety of Ustekinumab in Patients With Ulcerative Colitis
  Does the effectiveness and safety of ustekinumab seen in clinical trials translate to real-world clinical outcomes?

  March 23, 2023

• Real-World Comparison of Effectiveness Between Tofacitinib and Vedolizumab in Patients With Ulcerative Colitis Exposed to at Least One Anti-TNF Agent
  Which of these two drugs is the most effective option for ulcerative colitis patients who previously failed anti-TNF treatment?

  March 21, 2023

• Sleep Duration and Daytime Napping in Relation to Incident Inflammatory Bowel Disease
  To what extent is sleep dysregulation associated with the risk for incident IBD? A new study looks at the potential adverse effects of short sleep duration and daytime napping.

  March 14, 2023

• Controversies Surrounding the Use of Carvedilol and Other Beta Blockers in the Management of Portal Hypertension and Cirrhosis
  Whether carvedilol should be used in patients with portal hypertension and cirrhosis remains controversial. What does the available evidence say?

  March 09, 2023

• Faecal Microbiota Transplantation for Recurrent C. Difficile Infections
  This paper identifies key challenges and improvement opportunities for the use of fecal microbiota transplantation for recurrent C. diff infections.

  March 07, 2023

Table of Contents

2023 - 57 (6)

• Letter: comment on Park et al - the association of non-alcoholic fatty liver disease between parents and adolescent children. 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Editorial: moving from the clinic towards population hepatology. 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Editorial: definition of factors associated with poor quality of life in patients with IBS-but where to from here? 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Editorial: real-world evidence of tofacitinib and vedolizumab in ulcerative colitis-are we one step closer to better positioning therapies after anti-TNF failure? Authors' reply. 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Editorial: definition of factors associated with poor quality of life in patients with IBS-but where to from here? Authors' reply. 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Editorial: let's get physical-long-term benefits of vigorous physical activity in patients with nonalcoholic fatty liver disease. Authors' reply. 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Letter: comment on Park et al - the association of non-alcoholic fatty liver disease between parents and adolescent children - authors' reply. 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Letter: tricky reactions to switch back from subcutaneous to intravenous vedolizumab in inflammatory bowel disease patients-authors' reply. 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Editorial: real-world evidence of tofacitinib and vedolizumab in ulcerative colitis-are we one step closer to better positioning therapies after anti-TNF failure? 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Letter: tricky reactions to switch back from subcutaneous to intravenous vedolizumab in patients with inflammatory bowel disease. 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Letter: tofacitinib in the real world - do clinical trial data stand up? 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Editorial: let's get physical-long-term benefits of vigorous physical activity in patients with nonalcoholic fatty liver disease. 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Editorial: moving from the clinic towards population hepatology-authors' reply. 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Meta-analysis: Real-world effectiveness and safety of ustekinumab in patients with ulcerative colitis. 

  March 01, 2023

  • [ Full-text on Medscape ]
  • [ MEDLINE Abstract ]

• Systematic review with meta-analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease. 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin. 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Systematic review with network meta-analysis: Risk of Herpes zoster with biological therapies and small molecules in inflammatory bowel disease. 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Meta-analysis: Use of proton pump inhibitors and risk of gastric cancer in patients requiring gastric acid suppression. 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Meta-analysis: Efficacy and safety of albumin in the prevention and treatment of complications in patients with cirrhosis. 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Immune predictors of hepatitis B surface antigen seroconversion in patients with hepatitis B reactivation. 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Real-world comparison of effectiveness between tofacitinib and vedolizumab in patients with ulcerative colitis exposed to at least one anti-TNF agent. 

  March 01, 2023

  • [ Full-text on Medscape ]
  • [ MEDLINE Abstract ]

• Vigorous physical activity provides protection against all-cause deaths among adults patients with nonalcoholic fatty liver disease (NAFLD). 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]